The Scientist

» patent, developmental biology and culture

Most Recent

image: Cannibalism: Not That Weird

Cannibalism: Not That Weird

By | February 1, 2017

Eating members of your own species might turn the stomach of the average human, but some animal species make a habit of dining on their own.

5 Comments

image: From the Ground Up

From the Ground Up

By | February 1, 2017

Instrumental in launching Arabidopsis thaliana as a model system, Elliot Meyerowitz has since driven the use of computational modeling to study developmental biology.

0 Comments

image: Science Your Plants!

Science Your Plants!

By | February 1, 2017

CalTech researcher Elliot Meyerowitz describes how plant genetics influences growth and productivity.

1 Comment

image: Drug Approval Timeline Same as 20 Years Ago

Drug Approval Timeline Same as 20 Years Ago

By | January 9, 2017

A report finds that new medications still take about 12 years to go from patent to patient.

0 Comments

Children born to obese parents are at increased risk of failing motor development and cognitive tests, according to an NIH-led study.

0 Comments

image: Book Excerpt from <em>Testosterone Rex</em>

Book Excerpt from Testosterone Rex

By | January 1, 2017

In Chapter 6, “The Hormonal Essence of the T-Rex?” author Cordelia Fine considers the biological dogma that testes, and the powerful hormones they exude, are the root of all sexual inequality.

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | January 1, 2017

Science under Trump, gene drive, medical marijuana, and more

0 Comments

image: Repurposing Existing Drugs for New Indications

Repurposing Existing Drugs for New Indications

By | January 1, 2017

An entire industry has sprung up around resurrecting failed drugs and recycling existing compounds for novel indications.

1 Comment

image: Infographic: Repurposing Strategies

Infographic: Repurposing Strategies

By | January 1, 2017

Novel uses for existing and failed drugs may save companies time and money in bringing new therapeutics to market.

0 Comments

image: Life Science Controversies of 2016

Life Science Controversies of 2016

By , , and | December 23, 2016

This year, the developers of CRISPR gene-editing technology argued over patent rights, a researcher fought to unmask anonymous PubPeer commenters, US regulators considered “three-parent” babies, and troubles continued for Theranos.

0 Comments

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Grass Routes
    Features Grass Routes

    Researchers are discovering a suite of new locations and functions of endocannabinoid receptors that play roles in sickness and in health.

  3. Studies Retracted After UCLA Investigation
  4. Trump Nominates Sam Clovis to Lead USDA Research
AAAS